China NMPA Drug Inspection - Gansu Jinling Group Pharmaceutical Co., Ltd. - Tongmai Granules
China NMPA drug inspection for Gansu Jinling Group Pharmaceutical Co., Ltd. published December 03, 2019. Drug: Tongmai Granules. The Sichuan Provincial Drug Administration announced the findings from its 2019 Drug Sampling Inspection Work Plan on De
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Gansu Jinling Group Pharmaceutical Co., Ltd. published December 03, 2019. Drug: Tongmai Granules. The Sichuan Provincial Drug Administration announced the findings from its 2019 Drug Sampling Inspection Work Plan on De
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox